Abstract

The Advances in Targeted Therapies meets annually, convening experts in the field of rheumatology to both provide scientific updates and identify existing scientific gaps within the field. To review the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022
R Lories ... Ferry C Breedveld
Annals of the Rheumatic Diseases | VOL. 50
R Lories, et. al.R Lories ... Ferry C Breedveld
26 Jan 2023
Immunologic rheumatic disorders
Leslie Kahl ... Tammy P Cheng
The Journal of Allergy and Clinical Immunology | VOL. 125
Leslie Kahl, et. al.Leslie Kahl ... Tammy P Cheng
01 Feb 2010
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019
Maxime Dougados ... Joachim Kalden
Annals of the Rheumatic Diseases | VOL. 79
Maxime Dougados, et. al.Maxime Dougados ... Joachim Kalden
29 Oct 2019
OP0073 RISK OF DEVELOPING RHEUMATIC DISEASES IN PATIENTS WITH PALINDROMIC RHEUMATISM IN SOUTH KOREA: A NATION-WIDE POPULATION-BASED STUDY
J K Ahn ... J Hwang
-
J K Ahn, et. al.J K Ahn ... J Hwang
01 Jun 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers